In tumor cells, tamoxifen and its metabolites impede the binding of estrogen to the ER to inhibit expression of estrogen-responsive genes, thereby preventing tumor cell growth and angiogenesis6, 7. This evidence concerns the gene ESR1 and neoplasm.